FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma
OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy
100 Influential People in Oncology 2025 - Nominations are Open!
Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights
Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy
Enrique Soto: New ASCO Global Guideline on Geriatric Assessment
Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM
International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team
